Waypoint Capital Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,314
| Closed | -$7.88K | – | 121 |
|
|
2023
Q3 | $7.88K | Sell |
1,314
-599
| -31% | -$3.59K | ﹤0.01% | 115 |
|
|
2023
Q2 | $13.4K | Hold |
1,913
| – | – | ﹤0.01% | 132 |
|
|
2023
Q1 | $30K | Hold |
1,913
| – | – | 0.01% | 132 |
|
|
2022
Q4 | $38.3K | Buy |
+1,913
| New | +$38.3K | 0.01% | 128 |
|
|
2022
Q2 | – | Sell |
-2,219
| Closed | -$52K | – | 143 |
|
|
2022
Q1 | $52K | Buy |
+2,219
| New | +$52K | 0.03% | 116 |
|